BIOLASE Awarded New Patent for Delivering Sterile Water

BIOLASE Awarded New Patent for Delivering Sterile Water 
IRVINE, CA -- (Marketwired) -- 07/30/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, and a pioneer in laser surgery in other medical specialties,
announced today that the U.S. Patent and Trademark Office ("USPTO")
has issued BIOLASE(R) a new patent for delivering sterile water. This
new patent significantly expands on BIOLASE's fluid conditioning
system technology which is already covered in several issued U.S.
patents. Currently, BIOLASE holds over 180 issued patents in the
field of medical and dental laser technology, with several new patent
applications pending world-wide. 
U.S. Patent No. 8,485,818 is titled "Fluid Controller" and relates to
a new controlled way of delivering sterile water within the fluid
conditioning system of BIOLASE's revolutionary WaterLase(R) systems.
This technology will be used in both dental and medical cutting,
irrigating, evacuating, cleaning and drilling operations. An
additional important aspect of this new patent is the introduction of
disinfectant agents via spray, mist, or water stream used for dental
or surgical applications. 
Dmitri Boutoussov, Vice-President of Research and Development
commented, "The effectiveness and accuracy of WaterLase technology
for clinical applications is critically dependent on the extremely
precise control of the fluid flow. It is a core competency at BIOLASE
and key area of differentiation for us over all other hard-tissue
lasers in the market. It is challenging to precisely control fluids
at very low flow levels. Inkjet printers and fuel injection systems
are good examples of successful products in other industries. Our
ability to meet these challenges expands our ability to leverage this
technology into our targeted non-dental medical markets where the use
of sterile fluids is mandatory." 
"Off-the-shelf solutions were not able to meet our exacting
requirements, which motivated us to develop a whole new approach to
precisely control fluid flow with an integrated sterile and
disposable design. Success in practical implementation of our concept
will open doors for new medical applications of our laser
technology," concluded Boutoussov. 
Federico Pignatelli, Chairman and Chief Executive Officer, said,
"This is an exciting patent for BIOLASE. This latest patented
technology is a departure from conventional fluid flow control
systems and is expected to advance the efficacy and safety of laser
related surgical procedures where sterile fluids are required.
Further, while the ability to use the WaterLase for dental and
medical indications requiring a sterile water system is a major
advance, our IP in this patent family also covers fluid conditioning
with disinfectants, flavors, antibiotics and other conditioned fluid
particles which hold promise for future applications." 
This is the fifth U.S. patent issued in relation to groundbreaking
fluid conditioning laser technology with an additional U.S. patent
application pending.  
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets innovative lasers in dentistry
and medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment and CAD/CAM intraoral scanners; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's proprietary laser products
incorporate over 350 patented and patent-pending technologies
designed to provide biologically clinically superior performance with
less pain and faster recovery times. Its imaginative products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging equipment. BIOLASE
has sold more than 22,500 lasers. Other laser products under
development address ophthalmology and other medical and consumer
markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/biolaseinc and YouTube at
www.youtube.com/biolasevideos.  
BIOLASE(R) and WaterLase(R) are registered trademarks of BIOLASE,
Inc. 
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
212-564-4700 
 
 
Press spacebar to pause and continue. Press esc to stop.